Patients presenting with persistent abdominal pain and diarrhea are common in clinical practice. Inflammatory bowel disease (IBD) is always a possibility and while few will actually have IBD, the symptoms of inflammatory bowel syndrome (IBS) and IBD can overlap. Concern with a missed diagnosis of IBD leads many clinicians to request endoscopic evaluation.
The strategy of testing for fecal calprotectin utilizes non-invasive diagnostic testing to stratify patients in need of endoscopic confirmation, reducing costs and improving the overall patient healthcare experience.
Moderated by Dr. KT Park, MD, MS, produced by labroots and sponsored by Inova Diagnostics.
To view the recording of this FREE educational event* please use this link: Calprotectin Webinar*
*This Webinar is NOT eligible for Continuing Education Credits.